LON:ERGO

Ergomed plc (ERGO.L) Share Forecast, Price & News

GBX 1,090.50

-9.50 (-0.86 %)

(As of 01/27/2021 10:37 AM ET)

Add

Compare

Today's Range

1,060

Now: GBX 1,090.50▼

1,100

50-Day Range

945

MA: GBX 1,034.50▼

1,200

52-Week Range

258

Now: GBX 1,090.50▼

1,230

Volume176,555 shs

Average Volume135,259 shs

Market Capitalization£531.29 million

P/E Ratio87.24

Dividend YieldN/A

BetaN/A

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom and Rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Outsourcing and Pharmacovigilance. The company provides and manages clinical development, trial management, and pharmacovigilance services for pharmaceutical and generics companies, as well as small and mid-sized drug development companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, neurology, and CNS, as well as develops orphan drugs. The company also provides site support services. Ergomed plc was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.

MarketRank^™

Overall MarketRank^™

0.62 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Ergomed plc (ERGO.L).

3.1 Community Rank

Outperform Votes
Ergomed plc (ERGO.L) has received 233 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Ergomed plc (ERGO.L) has received 148 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Ergomed plc (ERGO.L) has received 61.15% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Ergomed plc (ERGO.L) and other stocks. Vote “Outperform” if you believe ERGO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ERGO will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Ergomed plc (ERGO.L) does not currently pay a dividend.
Dividend Growth
Ergomed plc (ERGO.L) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Ergomed plc (ERGO.L) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Ergomed plc (ERGO.L) is 84.80, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.16.
Price to Earnings Ratio vs. Sector
The P/E ratio of Ergomed plc (ERGO.L) is 84.80, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 37.13.
Price to Book Value per Share Ratio
Ergomed plc (ERGO.L) has a P/B Ratio of 11.70. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange LON

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolLON:ERGO

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.ergomedplc.com

Phone+44-1483-503205

Employees850

Year FoundedN/A

Debt

Debt-to-Equity Ratio48.12

Current Ratio1.44

Quick Ratio1.40

Price-To-Earnings

Trailing P/E Ratio87.24

Forward P/E Ratio1.32

P/E GrowthN/A

Sales & Book Value

Annual Sales£73.46 million

Price / Sales7.23

Cash FlowGBX 65.21 per share

Price / Cash Flow16.72

Book ValueGBX 90.60 per share

Price / Book12.04

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares48,719,500

Market Cap£531.29 million

Next Earnings DateN/A

OptionableNot Optionable

GBX 1,090.50

-9.50 (-0.86 %)

(As of 01/27/2021 10:37 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive ERGO News and Ratings via Email

Sign-up to receive the latest news and ratings for ERGO and its competitors with MarketBeat's FREE daily newsletter.

Ergomed plc (ERGO.L) (LON:ERGO) Frequently Asked Questions

How has Ergomed plc (ERGO.L)'s stock been impacted by COVID-19 (Coronavirus)?

Ergomed plc (ERGO.L)'s stock was trading at GBX 392 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ERGO shares have increased by 180.4% and is now trading at GBX 1,099.20.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Ergomed plc (ERGO.L)?

Wall Street analysts have given Ergomed plc (ERGO.L) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Ergomed plc (ERGO.L) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Ergomed plc (ERGO.L)'s earnings last quarter?

Ergomed plc (ERGO.L) (LON:ERGO) announced its quarterly earnings data on Monday, September, 18th. The company reported $1.20 EPS for the quarter. The business had revenue of $22.91 million for the quarter.
View Ergomed plc (ERGO.L)'s earnings history.

Who are some of Ergomed plc (ERGO.L)'s key competitors?

Some companies that are related to Ergomed plc (ERGO.L) include Trillium Therapeutics Inc. (TRIL.TO) (TRIL), Concordia International Corp. (CXR.TO) (CXR), 4D Molecular Therapeutics (FDMT), PureTech Health (PRTC), iTeos Therapeutics (ITOS), Novacyt S.A. (NCYT.L) (NCYT), Oxford Biomedica plc (OXB.L) (OXB), Inventiva (IVA), Biotest Aktiengesellschaft (BIO.F) (BIO), Aptose Biosciences (APS), Silence Therapeutics plc (SLN.L) (SLN), Burcon NutraScience Co. (BU.TO) (BU), Pfenex (PFNX), BioTime (BTX) and 22nd Century Group (XXII).
View all of ERGO's competitors.

What other stocks do shareholders of Ergomed plc (ERGO.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ergomed plc (ERGO.L) investors own include Dicerna Pharmaceuticals (DRNA), AbbVie (ABBV), Axsome Therapeutics (AXSM), FuelCell Energy (FCEL), NIO (NIO), Science Applications International (SAIC), Northern Dynasty Minerals (NAK), Tilray (TLRY), Agilent Technologies (A) and American Express (AXP).

Who are Ergomed plc (ERGO.L)'s key executives?

Ergomed plc (ERGO.L)'s management team includes the following people:

Dr. Miroslav Reljanovic, Founder & Exec. Chairman (Age 61, Pay $214.16k)
Mr. Richard T. Barfield, CFO & Exec. Director (Age 62, Pay $264.82k)
Ms. Sanja Juric, Gen. Counsel & Company Sec.
Ms. Dora Alvarado, Global Head of HR
Dr. Michael Forstner, Head of Risk Management & Pharmacoepidemiology
Ms. Roy Ovel, Chief Commercial Officer
Dr. Gordana Tonkovic, Pres of CRO
Mr. Jonathan West, Pres of PrimeVigilance

What is Ergomed plc (ERGO.L)'s stock symbol?

Ergomed plc (ERGO.L) trades on the London Stock Exchange (LON) under the ticker symbol "ERGO."

How do I buy shares of Ergomed plc (ERGO.L)?

Shares of ERGO and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Ergomed plc (ERGO.L)'s stock price today?

One share of ERGO stock can currently be purchased for approximately GBX 1,099.20.

How big of a company is Ergomed plc (ERGO.L)?

Ergomed plc (ERGO.L) has a market capitalization of £535.52 million and generates £73.46 million in revenue each year. Ergomed plc (ERGO.L) employs 850 workers across the globe.

What is Ergomed plc (ERGO.L)'s official website?

The official website for Ergomed plc (ERGO.L) is www.ergomedplc.com.

How can I contact Ergomed plc (ERGO.L)?

Ergomed plc (ERGO.L)'s mailing address is 26-24 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The company can be reached via phone at +44-1483-503205.

This page was last updated on 1/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Ergomed plc (ERGO.L) Share Forecast, Price & News

Adding

Adding

Adding Ergomed plc (ERGO.L)

MarketRank™

Overall MarketRank™